Drugs / 15-methyl prostaglandin F2α
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03584854 Comparator | Mar 2019 → May 2022 | uterine disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 15-methyl prostaglandin F2α | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03584854 ↗ |